Development of a Benzoxazine-derived Inhibitor Targeting Epithelial-to-Mesenchymal Transition in Lung Cancer
2,4-diMBD exerts anti-metastatic properties in lung cancer cells <i>via</i> EMT inhibition, and is a promising compound for the treatment of lung cancer.
Authors
- Pithi Chanvorachote (ORCID: https://orcid.org/0000-0002-3103-3249)
- Keerati Joyjamras (ORCID: https://orcid.org/0000-0003-4867-4760)
- Worawat Wattanathana (ORCID: https://orcid.org/0000-0002-3592-3708)
- Zin Zin (ORCID: https://orcid.org/0000-0001-7906-0986)
- Acharawan Thongmee
- Bhurichaya Innets
- Naphatson Phansom
- Theera Rittirod
Institutions
- Chulalongkorn University (TH)
- Khon Kaen University (TH)
- Kasetsart University (TH)
- Maharat Nakhon Ratchasima Hospital (TH)
- Nakhon Ratchasima Rajabhat University (TH)
- Silpakorn University (TH)
- Rangsit University (TH)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/anticanres.17649
- Primary Topic
- Synthesis and Biological Evaluation
- Type
- article
- Field-Weighted Citation Impact
- 0.00